( NYSE:NVRO )

News from Nevro Corp. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Dec 01, 2017, 10:56 ET Nevro erhält CE-Kennzeichnung für Senza II™ Rückenmark-Stimulationssystem zur Bereitstellung der HF10™-Therapie

Überlegene opiumfreie Therapie wird jetzt über kleineren und verfeinerten IPG abgegeben Nevro Corp. (NYSE:NVRO), ein global tätiges...


Dec 01, 2017, 10:37 ET Nevro obtient le marquage CE pour Senza II™, son système de stimulation de la moelle épinière administrant la thérapie HF10™

Cette thérapie de pointe sans opioïdes est désormais administrée dans un générateur implantable d'impulsions plus petit et affiné...


Dec 01, 2017, 08:44 ET Nevro recibe el marcado CE por el sistema de estimulación espinal Senza II™ para la administración de la terapia HF10™

- Nevro recibe el marcado CE por el sistema de estimulación de médula espinal Senza II™ para la administración de la terapia HF10™ Terapia...


Dec 01, 2017, 04:40 ET Společnost Nevro získala označení CE pro systém míšní stimulace Senza II™ umožňující terapii HF10™

Dokonalá, neopioidní terapie, která je nyní dodávána v menším a rafinovanějším implantabilním pulzním generátoru (IPG) Nevro Corp....


Dec 01, 2017, 04:35 ET Nevro získava CE označenie pre systém miechovej stimulácie Senza II™ zabezpečujúci liečbu HF10™

Kvalitná neopioidná terapia teraz odskúšaná prostredníctvom malého a presnejšieho implantovateľného generátora impulzov. Nevro Corp....


Nov 30, 2017, 19:22 ET Nevro otrzymuje oznakowanie CE na system stymulacji rdzenia kręgowego Senza II™ w terapii HF10™

Lepsza, nieopioidowa terapia realizowana w mniejszym i dokładniejszym trybie IPG Firma Nevro Corp. (NYSE:NVRO), globalne przedsiębiorstwo...


Nov 30, 2017, 16:30 ET Nevro получает маркировку СЕ для системы ССМ Senza II™, обеспечивающей осуществление терапии HF10™

Высокорезультативный метод терапии без применения опиоидов отныне реализуется устройством уменьшенного размера и оптимизированной конструкции...


Nov 06, 2017, 16:10 ET Nevro Reports Third Quarter 2017 Financial Results

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Oct 23, 2017, 16:09 ET Nevro to Report Operating Results for the Third Quarter 2017

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Aug 24, 2017, 16:09 ET Nevro to Present at Upcoming Investor Conferences

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Aug 07, 2017, 16:14 ET Nevro Reports Second Quarter 2017 Financial Results

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Jul 26, 2017, 16:10 ET Nevro to Present at the Canaccord Genuity Growth Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Jul 24, 2017, 16:09 ET Nevro to Report Operating Results for the Second Quarter 2017

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Jul 05, 2017, 06:59 ET Nevro Announces Preliminary Unaudited Second Quarter 2017 Revenue and Business Update

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Jun 28, 2017, 18:41 ET EY Announces Rami Elghandour, President and CEO of Nevro, as 2017 Entrepreneur Of The Year®

Nevro Corp., a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain, today...


Jun 15, 2017, 18:45 ET Neurosurgery Selects the SENZA-RCT 24-Month Outcomes Publication as the Top Pain Paper of the Year

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


May 30, 2017, 16:10 ET Nevro to Present at the William Blair Growth Stock Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


May 08, 2017, 16:10 ET Nevro Reports First Quarter 2017 Financial Results

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


May 02, 2017, 16:10 ET Nevro to Present at the Bank of America Merrill Lynch 2017 Health Care Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic...


Apr 24, 2017, 16:10 ET Nevro to Report Operating Results for the First Quarter 2017

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Feb 23, 2017, 16:10 ET Nevro Reports Fourth Quarter and Full Year 2016 Financial Results and Provides 2017 Outlook

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Feb 09, 2017, 16:10 ET Nevro to Report Operating Results for the Fourth Quarter and Full Year 2016

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Dec 22, 2016, 16:10 ET Nevro to Present at the 35th Annual J.P. Morgan Healthcare Conference

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Dec 09, 2016, 17:22 ET Nevro Announces Filing of Lawsuit by Boston Scientific

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...


Nov 28, 2016, 18:25 ET Nevro Files Lawsuit for Patent Infringement Against Boston Scientific in the U.S.

Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative evidence-based solutions for the treatment of chronic pain,...